Globe Newswire01.27.22
Vivos Therapeutics Inc. and Candid Care Co. are teaming up to provide a whole-mouth solution to obstructive sleep apnea (OSA) and snoring.
The two companies will market each other’s products and areas of expertise to provide a comprehensive sleep and oral health solution to U.S. and Canadian patients. The focus of the collaboration is Candid’s CandidPro clear aligner for straightening teeth and the Vivos System for treating OSA. The two companies also are sharing educational resources, training, and key opinion leaders to bridge the gap between airway health and orthodontic therapy.
“By teaming with Candid, we are aiming to provide patients with access not only to our Vivos System, but also simultaneous access to CandidPro’s novel orthodontic treatment. We believe the Vivos-Candid collaboration will provide for the first solution that seamlessly integrates sleep and orthodontic therapy to create better patient outcomes for treating OSA and enhance overall health and wellness across the board.” said Kirk Huntsman, Vivos chairman and CEO. “We are hopeful that this joint effort will increase market penetration and accelerate revenue growth for both companies as we each attract and expand our respective North American dental and healthcare networks.”
Additionally, Vivos and Candid will jointly explore new R&D opportunities for device development and other alliances related to orthodontics, OSA, and snoring. Candid will also conduct specialized training sessions at the Vivos Institute, the company’s new state-of-the-art international training center in Denver, as well as semi-annual seminars for both dentists and medical doctors to provide additional learning opportunities. The parties will act on a non-exclusive basis, although during the term of the agreement, Candid’s aligners will become the official clear aligner of Vivos and Vivos’ oral devices and proprietary protocols will become the official sleep therapy program of Candid.
“Candid was built on a foundation of clinical excellence and has always put patient health first. Since launching Candid in 2017, my co-founders and I have strived to shine a light on the correlation between teeth alignment, oral health, and chronic illnesses, like obstructive sleep apnea. Vivos Therapeutics and Candid are where airway and sleep, oral health, and orthodontic therapy come together for the first time,” added Nick Greenfield, Candid co-founder and CEO. “By combining Vivos’ therapeutic protocol for OSA and its VIP doctor network with Candid's treatment methodology and CandidPro network, together we look forward to offering a full-service solution for patients suffering from OSA.”
“As someone who focuses his practice on combining sleep-disordered breathing, orthodontics and comprehensive dentistry, I know how important it is to treat all oral health conditions as part of one comprehensive solution,” concluded Dr. Ben Miraglia, DDS, chief clinical consultant of Airway Health Solutions, Vivos provider and recognized thought leader in sleep-disordered breathing, clear aligner therapy and craniofacial development. “The Vivos-Candid alliance is a true win-win for patients who are looking to improve their sleep, oral health and confidence all at the same time.”
Vivos Therapeutics is focused on developing and commercializing diagnostics and treatments for adult patients suffering from mild-to-moderate obstructive sleep apnea. The Vivos treatment involves customized oral appliances and treatment protocols called the Vivos System—oral appliance technology that represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for adults with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivos’ oral appliances have proven effective in over 19,000 patients treated worldwide by more than 1,250 trained dentists.
Combining proprietary technologies and protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology, for home sleep testing in adults and children.
Candid is a digital platform for oral healthcare. Coupling the expertise and attention of private practice orthodontics with the convenience and affordability of telehealth, Candid delivers the best of both worlds. Its patent-pending approach to treatment planning and intuitive ecosystem of hardware and software offer superior care and outcomes. CandidPro provides enhanced features and services exclusively available for cases started and finished inside the dental practice.
The two companies will market each other’s products and areas of expertise to provide a comprehensive sleep and oral health solution to U.S. and Canadian patients. The focus of the collaboration is Candid’s CandidPro clear aligner for straightening teeth and the Vivos System for treating OSA. The two companies also are sharing educational resources, training, and key opinion leaders to bridge the gap between airway health and orthodontic therapy.
“By teaming with Candid, we are aiming to provide patients with access not only to our Vivos System, but also simultaneous access to CandidPro’s novel orthodontic treatment. We believe the Vivos-Candid collaboration will provide for the first solution that seamlessly integrates sleep and orthodontic therapy to create better patient outcomes for treating OSA and enhance overall health and wellness across the board.” said Kirk Huntsman, Vivos chairman and CEO. “We are hopeful that this joint effort will increase market penetration and accelerate revenue growth for both companies as we each attract and expand our respective North American dental and healthcare networks.”
Additionally, Vivos and Candid will jointly explore new R&D opportunities for device development and other alliances related to orthodontics, OSA, and snoring. Candid will also conduct specialized training sessions at the Vivos Institute, the company’s new state-of-the-art international training center in Denver, as well as semi-annual seminars for both dentists and medical doctors to provide additional learning opportunities. The parties will act on a non-exclusive basis, although during the term of the agreement, Candid’s aligners will become the official clear aligner of Vivos and Vivos’ oral devices and proprietary protocols will become the official sleep therapy program of Candid.
“Candid was built on a foundation of clinical excellence and has always put patient health first. Since launching Candid in 2017, my co-founders and I have strived to shine a light on the correlation between teeth alignment, oral health, and chronic illnesses, like obstructive sleep apnea. Vivos Therapeutics and Candid are where airway and sleep, oral health, and orthodontic therapy come together for the first time,” added Nick Greenfield, Candid co-founder and CEO. “By combining Vivos’ therapeutic protocol for OSA and its VIP doctor network with Candid's treatment methodology and CandidPro network, together we look forward to offering a full-service solution for patients suffering from OSA.”
“As someone who focuses his practice on combining sleep-disordered breathing, orthodontics and comprehensive dentistry, I know how important it is to treat all oral health conditions as part of one comprehensive solution,” concluded Dr. Ben Miraglia, DDS, chief clinical consultant of Airway Health Solutions, Vivos provider and recognized thought leader in sleep-disordered breathing, clear aligner therapy and craniofacial development. “The Vivos-Candid alliance is a true win-win for patients who are looking to improve their sleep, oral health and confidence all at the same time.”
Vivos Therapeutics is focused on developing and commercializing diagnostics and treatments for adult patients suffering from mild-to-moderate obstructive sleep apnea. The Vivos treatment involves customized oral appliances and treatment protocols called the Vivos System—oral appliance technology that represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for adults with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivos’ oral appliances have proven effective in over 19,000 patients treated worldwide by more than 1,250 trained dentists.
Combining proprietary technologies and protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology, for home sleep testing in adults and children.
Candid is a digital platform for oral healthcare. Coupling the expertise and attention of private practice orthodontics with the convenience and affordability of telehealth, Candid delivers the best of both worlds. Its patent-pending approach to treatment planning and intuitive ecosystem of hardware and software offer superior care and outcomes. CandidPro provides enhanced features and services exclusively available for cases started and finished inside the dental practice.